In an attempt to predict the response to mTOR inhibitors, an interesting study showed that the level of phosphorylated S6 ribosomal protein expression, reflecting the mTOR pathway activation, was predictive of early tumor response to the drug [115]. The gene discussed is RPS6; the disease is neoplasm.